An online tool for patients with ulcerative colitis and low-grade dysplasia can help them consider their options for reducing their risk for developing colorectal cancer.
The risk assessment tool “provides the user with the patient’s predicted cumulative risk of high-grade dysplasia and colorectal cancer risk, both quantitatively and in terms of percentage chance at yearly follow-up over a 10-year period,” explained Misha Kabir, MD, a research fellow at St.